Chester County News and Community Website
MALVERN, PA — CubeSmart (NYSE: CUBE) announced it will release financial results for the third quarter of 2025 after market close on Thursday, October 30. The Company will host a …
CubeSmart to Report Q3 2025 Results on October 30 Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that its leadership team will present at three upcoming industry and investor events: the 2025 Cell & Gene Meeting on the Mesa, …
Ocugen to Highlight Gene Therapy Pipeline at Key Industry and Investor Conferences Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced it will hold its 2025 R&D Day in Midtown, New York, on Tuesday, October 14, at 8:00 a.m. ET. The event …
Aclaris to Host 2025 R&D Day in New York to Spotlight Immuno-Inflammatory Pipeline Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has signed an exclusive licensing agreement with South Korea’s Kwangdong Pharmaceutical Co., Ltd. for the rights to commercialize OCU400, its experimental modifier gene …
Ocugen Strikes $7.5 Million Licensing Deal With Kwangdong for Gene Therapy in Korea Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) will present its latest semiconductor and passive component technologies at PCIM Asia 2025 in Shanghai, highlighting solutions for artificial intelligence (AI) infrastructure …
Vishay to Showcase AI and EV Power Solutions at PCIM Asia 2025 Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that its partner Torii Pharmaceutical Co. Ltd., now a subsidiary of Shionogi & Co., Ltd., has received approval from Japan’s …
Verrica Secures $10 Million Milestone as YCANTH Wins Approval in Japan Read More
EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) announced its Board of Directors has declared a regular quarterly dividend of $0.34 per share. The dividend will be paid on October …
Omega Flex Declares $0.34 Quarterly Dividend Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has signed an exclusive licensing agreement with South Korea’s Kwangdong Pharmaceutical Co., Ltd. for the rights to develop and commercialize OCU400, Ocugen’s experimental …
Ocugen Strikes $187.5 Million Licensing Deal With Kwangdong for Gene Therapy in Korea Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) announced its Board of Directors has declared a third-quarter dividend of $0.07 per share. The dividend will be paid on September 30, …
Bentley Systems Declares $0.07 Quarterly Dividend Read More
WAYNE, PA — Ecovyst Inc. (NYSE: ECVT) has entered into a definitive agreement to divest its Advanced Materials & Catalysts segment to Technip Energies for $556 million, a deal that …
Ecovyst to Sell Advanced Materials & Catalysts Unit to Technip Energies for $556 Million Read More